| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 01/07/2010 | WO2010001869A1 Tetra-substituted benzene compound and use thereof |
| 01/07/2010 | WO2010001185A1 Thieno [2,3-b] pyridine compounds with mglur activity |
| 01/07/2010 | WO2010001096A2 Treatment |
| 01/07/2010 | WO2010000404A1 Oxazolidinones for the treatment of inflammatory conditions of the gastrointestinal tract |
| 01/07/2010 | WO2009140204A3 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 01/07/2010 | WO2009066309A3 Process for preparation of omeprazole |
| 01/07/2010 | WO2009007532A3 Use of a haemoglobin for the preparation of dressings and resulting dressings |
| 01/07/2010 | US20100004458 Process for producing crystal |
| 01/07/2010 | US20100004291 Liquid dosage forms of non-enterically coated acid-labile drugs |
| 01/07/2010 | US20100004261 Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase |
| 01/07/2010 | US20100004246 Novel triazinedione derivatives as gabab receptor modulators |
| 01/07/2010 | US20100004213 Gene expression markers for inflammatory bowel disease |
| 01/07/2010 | US20100004203 Medicament for preventive and/or therapeutic treatment of bowel disease |
| 01/07/2010 | US20100004192 4'-Substituted Nucleoside Derivatives as Inhibitors of HCV RNA Replication |
| 01/07/2010 | US20100004157 Pharmaceutical compositions for the oral or rectal administration of protein substances |
| 01/07/2010 | US20100003348 Use of clays for treating coeliac disease |
| 01/07/2010 | US20100003333 Compositions and methods for treating digestive disorders |
| 01/07/2010 | US20100003248 Polypeptide constructs for rectal and/or vaginal administration |
| 01/07/2010 | US20100003235 Oral formulations for enteric disorders and/or rehydration |
| 01/07/2010 | US20100003225 Hsp60, hsp60 peptides and t cell vaccines for immunomodulation |
| 01/07/2010 | US20100003213 4'-substituted nucleoside derivatives as inhibitors of hcv rna replication |
| 01/07/2010 | CA2729687A1 Oxazolidinones for the treatment of inflammatory conditions of the gastrointestinal tract |
| 01/07/2010 | CA2729582A1 Particles containing an opioid receptor antagonist and methods of use |
| 01/07/2010 | CA2729412A1 Novel spirochromanone carboxylic acids |
| 01/07/2010 | CA2728492A1 Treatment |
| 01/06/2010 | EP2141150A1 Bicyclic compound and pharmaceutical use thereof |
| 01/06/2010 | EP2141148A1 Indole derivative having cpla2 inhibitory activity, use of the same and method for producing the same |
| 01/06/2010 | EP2141146A1 Calcilytic compounds |
| 01/06/2010 | EP2140874A1 Remedy for acute hepatitis or preventive/remedy for fulminant hepatitis |
| 01/06/2010 | EP2140866A1 Oxazolidinones for the treatment of inflammatory conditions of the gastrointestinal tract |
| 01/06/2010 | EP2140771A1 Method for stimulating the intestinal flora in infants delivered by caesarean section |
| 01/06/2010 | EP2139994A2 2786, a human aminopeptidase |
| 01/06/2010 | EP2139508A2 Klotho-beta for use in treating cancer, liver disorders, gallstones, wasting syndrome and obesity-related diseases |
| 01/06/2010 | EP2139506A1 Composition comprising rehmanniae radix preparata, notoginseng radix or mixture extract thereof for preventing and treating of periodontitis as an effective component |
| 01/06/2010 | EP2139505A2 Novel pharmaceutical composition for use as a laxative |
| 01/06/2010 | EP2139462A2 Calcimimetic compounds for use in the treatment of bowel disorders |
| 01/06/2010 | EP1687015B1 Compositions for the treatment of diseases of the oral cavity and upper respiratory tract |
| 01/06/2010 | EP1513831B1 Novel compounds, their use and preparation |
| 01/06/2010 | CN100577685C Long-acting thymosin alpha1 polyethylene glycol modifier |
| 01/06/2010 | CN100577681C Compounds, compositions and methods for treatment of inflammatory diseases and conditions |
| 01/06/2010 | CN100577662C Setron-like compounds, preparation method and medicament use thereof |
| 01/06/2010 | CN100577196C Medicine for treating gastric ulcer and duodenal ulcer |
| 01/06/2010 | CN100577193C Health product for sobering-up |
| 01/06/2010 | CN100577185C Chinese medicine red sage-astragalus root preparation for treating liver fibrosis and liver cirrhosis and its preparation process |
| 01/06/2010 | CN100577173C Adefovir dipivoxil self-emulsifiable preparation and its preparing method |
| 01/06/2010 | CN100577161C New application of dendrobine |
| 01/05/2010 | US7642903 Trailer tire alert system |
| 01/05/2010 | US7642378 Lipid lowering biphenylcarboxamides |
| 01/05/2010 | US7642351 2,4-Pyrimidinediamine compounds and their uses |
| 01/05/2010 | US7642276 N-[4-methyl-3-(3-piperidin-4-yl-1,2-benzisoxazol-6-yl)phenyl]-2-pyrrolidin-1-ylisonicotinamide; rheumatoid arthritis |
| 01/05/2010 | US7642261 Treating bipolar disorder, mania, dementia, sexual dysfunction, eating disorders, fibromyalgia |
| 01/05/2010 | US7642081 Lactic acid bacteria and their cellular components inducing immunoregulatory function, and method of obtaining the same |
| 01/05/2010 | US7641922 Preparation and application of transhintotalphenolic acid |
| 01/05/2010 | US7641901 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 01/05/2010 | CA2545999C 1,2-di(cyclic)substituted benzene compounds |
| 01/05/2010 | CA2449098C Pharmaceutical compositions for the coordinated delivery of nsaids |
| 01/05/2010 | CA2426457C Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 01/05/2010 | CA2425319C Treatment and prophylaxis of diseases and infections of pigs and poultry |
| 01/05/2010 | CA2405796C Methods and compositions for modulating alpha adrenergic receptor activity |
| 01/05/2010 | CA2392081C Pharmaceutically active isoindoline derivatives |
| 01/05/2010 | CA2349475C Production of a biological factor and creation of an immunologically privileged environment using genetically altered sertoli cells |
| 01/05/2010 | CA2182810C Bacteriocin from micrococcus varians |
| 12/31/2009 | US20090326038 Method for treating a immunology-related disease |
| 12/31/2009 | US20090326026 Tricyclic Compounds Useful as Angiotensin II Agonists |
| 12/31/2009 | US20090326021 Thiazolo naphthyl acids |
| 12/31/2009 | US20090326004 Muscarinic receptor antagonists |
| 12/31/2009 | US20090325995 Mixing a water-insoluble opioid, a water-soluble carrier, and a solvent for each of the opioid and the carrier; spray-drying the mixture to remove the solvent and obtain a substantially solvent-free nanodispersion of the opioid; in the carrier; oral administration; drug delivery |
| 12/31/2009 | US20090325988 Glucocorticoid Mimetics, Methods of Making Them, Pharmaceutical Compositions and Uses Thereof |
| 12/31/2009 | US20090325982 Phosphodiesterase 4 inhibitors |
| 12/31/2009 | US20090325962 Tyrosine derivative |
| 12/31/2009 | US20090325960 Method for treating inflammatory diseases using rho kinase inhibitor compounds |
| 12/31/2009 | US20090325950 Benzoxazine derivatives and uses thereof |
| 12/31/2009 | US20090325880 Tnf receptor-like molecules and uses thereof |
| 12/31/2009 | US20090325865 Liquid Formulations of Pegylated Growth Hormone |
| 12/31/2009 | US20090325289 Process for the multiplication of stem cells |
| 12/31/2009 | US20090324761 Methods And Compositions for Improving Gastrointestinal Health |
| 12/31/2009 | US20090324758 Plant extract mixtures and their uses |
| 12/31/2009 | US20090324757 Compositions and Methods for Modulating Visceral Sensation and/or Gastrointestinal Reflex Activity |
| 12/31/2009 | US20090324755 Method for the production of a plant-based medicament |
| 12/31/2009 | US20090324599 activates FGF receptors, regulates the growth and differentiation of cells within the liver, regulates other cell types following secretion from the liver, plays a role in liver chemotaxis, has an oncogenic activity, or serves as an antigen for generating antibodies; treating diabetes or obesity |
| 12/31/2009 | US20090324598 Method for the treatment of inflammatory disorders |
| 12/31/2009 | US20090324574 Esterases and Related Nucleic Acids and Methods |
| 12/31/2009 | US20090324545 Polymorphic forms of (s)-1-tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl)phenyl)ureido)benzyl carbamate |
| 12/31/2009 | DE102008002685A1 Verfahren zur Herstellung eines Arzneimittels auf pflanzlicher Basis A process for preparing a pharmaceutical composition based on plants |
| 12/30/2009 | WO2009158625A2 Compositions and methods for treating or preventing gastrointestinal disorders and gerd-related respiratory disorders |
| 12/30/2009 | WO2009158384A1 Methods and kits for the treatment inhibition, and maintenance of gastrointestinal disorders |
| 12/30/2009 | WO2009157858A1 Use of cyclolignans for the treatment of a hyperactive immune system |
| 12/30/2009 | WO2009157559A1 Pancreatic cell regeneration/transplantation kit for pancreatic diseases or diabetes |
| 12/30/2009 | WO2009157418A1 Carboxylic acid compound |
| 12/30/2009 | WO2009157398A1 Therapeutic agent for inflammatory bowel disease |
| 12/30/2009 | WO2009157397A1 Therapeutic agent for intestinal tract injury accompanying administration of a non-steroid anti-inflammatory agent |
| 12/30/2009 | WO2009155711A1 Analysis of lactobacillus acidophilus la-5 signal interference molecules |
| 12/30/2009 | WO2009131957A8 Compounds, compositions and methods comprising oxadiazole derivatives |
| 12/30/2009 | WO2009106708A3 Azetidine derivatives, their preparation and their application in therapy |
| 12/30/2009 | EP2138497A1 Novel adenine compound |
| 12/30/2009 | EP2138484A1 Fused bicyclic heteroaryl derivatives |
| 12/30/2009 | EP2138190A2 Compositions comprising dietary fat complexer and methods for their use |
| 12/30/2009 | EP2138182A2 Method for producing medicine based on herbs |
| 12/30/2009 | EP2138175A2 Formulations comprising valsartan for treating diabetes or microalbuminuria |
| 12/30/2009 | EP2137155A1 Quinoline derivatives, pharmaceutical compositions comprising them, and their use in treating central nervous system and peripheral diseases |